Innocore Pharma is a privately owned company based in The Netherlands, specializing in formulation, process development, and manufacturing of long-acting and minimally invasive injectable drug delivery products. With a strong focus on target-driven and cost-efficient practices, Innocore Pharma is committed to delivering products and services that provide added value to their partners and enhance the quality of life for patients. Their expertise lies in developing polymer-based depot formulation products for precise delivery of small molecules, peptides, and protein therapeutics, contributing to enhanced patient care.

With flexibility, compliance with international quality standards, and a belief in the power of collaborative partnerships, Innocore Pharma offers a comprehensive range of services. With a successful track record, Innocore Pharma has been involved in notable projects, including the development of a long-acting injectable contraceptive implant, supported by the Bill and Melissa Gates Foundation, and a partnership agreement with Merck KGaA. They have also received prestigious awards and achieved important certifications in their field.

For more information about Innocore Pharma and their cutting-edge technologies, feel free to connect with them. Contact details can be found on their website